Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
World Journal of Nuclear Medicine|November 12, 2025
Improving Equitable Cancer Treatment in Australia: The Case for Theranostics in the Northern TerritoryJoshua J Morigi, Suzanne McGavinCurrent Opinion in Urology|July 29, 2016
Rapidly changing landscape of PET/CT imaging in prostate cancerJoshua J Morigi, S Fanti, D Murphy, et al.Minerva Urology and Nephrology|June 19, 2020
Prostate specific membrane antigen positron emission tomography/computed tomography and staging high risk prostate cancer: a non-systematic review of high clinical impact literatureJoshua J Morigi, Jack Anderson, Cosimo DE Nunzio, et al.Tropical Medicine and Infectious Disease|March 26, 2025
18-Fluorine-Fluorodeoxyglucose Positron Emission Computer Tomography Imaging in Melioidosis: Valuable but Not EssentialJoshua Bramwell, Natalia Kovaleva, Joshua J Morigi, et al.Current Opinion in Urology|July 24, 2020
Where to next prostate-specific membrane antigen PET imaging frontiers?Maarten L Donswijk, Joshua J Morigi, Adrienne Little, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 27, 2015
Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted TherapyJoshua J Morigi, Phillip D Stricker, Pim J van Leeuwen, et al.The Lancet. Oncology|June 10, 2026
Effect of [68Ga]Ga-PSMA-11 PET-CT in the diagnosis of prostate cancer in men with equivocal or clinically high-risk non-suspicious findings on multiparametric MRI (PRIMARY2): a multicentre, non-inferiority, phase 3, randomised controlled trialJames P Buteau, Daniel Moon, Michael T Fahey, et al.Pageof 1